Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Discovery Technologies
  4. Fast Track Articles
  5. Fast Track Article
image of An Update on Clinically Evaluated Medicinal Plants for Psoriasis Management

Abstract

Psoriasis is a prevalent inflammatory disease affecting almost 0.5-5% of the world population. Multiple treatment approaches have been developed to manage psoriasis so far. Although concerns exist in the long-term usage of conventional and biological agents in terms of safety, effectiveness, expensiveness, and tolerability, complementary and alternative medicine (CAM) is a promising point of view for future psoriasis management. In this study, databases including Scopus, PubMed, Google Scholar, and Web of Science were searched for relevant literature on herbal medications clinically evaluated for psoriasis, especially those originating from traditional medicine. About 40 relevant papers were selected by March 2023. Most of the studies were clinical trials on poly-herbal formulations from traditional Chinese medicine (TCM). There are controversial results regarding the efficacy of these herbal formulations in psoriasis mainly due to the variation in the study design. Moreover, the probable protective mechanisms and responsible herbal metabolites of these formulations are summarized. There is a global need for more in-vitro and in-vivo studies based on the standard protocols in terms of the evaluation of the safety and efficacy of topical/ systemic herbal preparations for psoriasis.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638327441241016014503
2024-10-28
2024-11-29

  • From This Site

    /content/journals/cddt/10.2174/0115701638327441241016014503
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Soleymani T. Reddy S.M. Cohen J.M. Neimann A.L. Early recognition and treatment heralds optimal outcomes: The benefits of combined rheumatology–dermatology clinics and integrative care of psoriasis and psoriatic arthritis patients. Curr. Rheumatol. Rep. 2018 20 1 1 10.1007/s11926‑017‑0706‑0 29185062
    [Google Scholar]
  2. Altekin E.R. Koç S. Karakaş M.S. Yanıkoğlu A. Başarıcı I. Demir I. Alpsoy E. Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis. Turk Kardiyol. Dern. Ars. 2012 40 7 574 580 10.5543/tkda.2012.54920 23363939
    [Google Scholar]
  3. Lone A. Ahmad T. Naiyar A.H. Clinical evaluation of efficacy of Majoon Ushba and Roghane Hindi in the management of psoriasis: A randomized single-blind, placebo-controlled study. J. Ayurveda Integr. Med. 2011 2 1 26 31 10.4103/0975‑9476.78188 21731384
    [Google Scholar]
  4. Nițescu D. Mușetescu A. Nițescu M. Costescu M. Coman O.A. Experimental research in topical psoriasis therapy (Review). Exp. Ther. Med. 2021 22 3 971 10.3892/etm.2021.10403 34335913
    [Google Scholar]
  5. Lee E.B. Wu K.K. Lee M.P. Bhutani T. Wu J.J. Psoriasis risk factors and triggers. Cutis 2018 102 5S 18 20 30566552
    [Google Scholar]
  6. Kim W.B. Jerome D. Yeung J. Diagnosis and management of psoriasis. Can. Fam. Physician 2017 63 4 278 285 28404701
    [Google Scholar]
  7. Damevska K. França K. Lotti T. Nikolovska S. Pollozhani N. Complementary and integrative therapies for psoriasis: Looking forward. Dermatol. Ther. 2018 31 5 e12627 10.1111/dth.12627 30133906
    [Google Scholar]
  8. Coumbe A.G. Pritzker M.R. Duprez D.A. Cardiovascular risk and psoriasis: Beyond the traditional risk factors. Am. J. Med. 2014 127 1 12 18 10.1016/j.amjmed.2013.08.013 24161194
    [Google Scholar]
  9. Qu X.A. Freudenberg J.M. Sanseau P. Rajpal D.K. Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: A psoriasis case study. Drug Discov. Today 2014 19 9 1364 1371 10.1016/j.drudis.2014.03.015 24662034
    [Google Scholar]
  10. Subbaiah K.V. Savithramma N. Bio-prospecting and documentation of traditional medicinal plants used to treat itching, psoriasis and wounds by ethnic groups of kurnool district, Andhra Pradesh, India. Asian J. Pharm. Clin. Res. 2012 5 2 127 131
    [Google Scholar]
  11. Guenther L.C. Combination therapy of biologics with traditional agents in psoriasis. Skin Therapy Lett. 2011 16 6 1 3 21833461
    [Google Scholar]
  12. de Alcantara C.C. Reiche E.M.V. Simão A.N.C. Cytokines in psoriasis. Adv. Clin. Chem. 2021 100 171 204 10.1016/bs.acc.2020.04.004 33453865
    [Google Scholar]
  13. Brandon A. Mufti A. Gary Sibbald R. Diagnosis and management of cutaneous psoriasis: A review. Adv. Skin Wound Care 2019 32 2 58 69 10.1097/01.ASW.0000550592.08674.43 30653184
    [Google Scholar]
  14. Timis T.L. Florian I.A. Vesa S.C. Mitrea D.R. Orasan R.I. An updated guide in the management of psoriasis for every practitioner. Int. J. Clin. Pract. 2021 75 8 e14290 10.1111/ijcp.14290 33928703
    [Google Scholar]
  15. Kodali N. Blanchard I. Kunamneni S. Lebwohl M.G. Current management of generalized pustular psoriasis. Exp. Dermatol. 2023 32 8 1204 1218 10.1111/exd.14765 36779681
    [Google Scholar]
  16. Korman N.J. Management of psoriasis as a systemic disease: What is the evidence? Br. J. Dermatol. 2020 182 4 840 848 10.1111/bjd.18245 31225638
    [Google Scholar]
  17. Castrejón I. Gibson K.A. Pincus T. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis. Bull. Hosp. Jt. Dis. 2013 71 Suppl. 1 S20 S28 24219037
    [Google Scholar]
  18. Kalb RE Pustular psoriasis: Management. 2014 Available From: https://medilib.ir/uptodate/show/93554
  19. Brownstone N.D. Hong J. Mosca M. Hadeler E. Liao W. Bhutani T. Koo J. Biologic treatments of psoriasis: An update for the clinician. Biologics 2021 15 39 51 33623366
    [Google Scholar]
  20. Talbott W. Duffy N. Complementary and alternative medicine for psoriasis: What the dermatologist needs to know. Am. J. Clin. Dermatol. 2015 16 3 147 165 10.1007/s40257‑015‑0128‑6 25904522
    [Google Scholar]
  21. Capella G.L. Finzi A.F. Complementary therapy for psoriasis. Dermatol. Ther. 2003 16 2 164 174 10.1046/j.1529‑8019.2003.01625.x 12919118
    [Google Scholar]
  22. Kurilić M. Brajac I. Massari L.P. Kaštelan M. Traditional systemic therapy-role in the treatment of psoriasis. Medicina: Glasilo Hrvatskoga liječničkoga zbora. Podružnica Rijeka. 2011 47 1 53 58
    [Google Scholar]
  23. Bissonnette R. Ho V. Langley R.G. Safety of conventional systemic agents and biologic agents in the treatment of psoriasis. J. Cutan. Med. Surg. 2009 13 5_suppl Suppl. 2 S67 S76 10.2310/7750.2009.00023 19799829
    [Google Scholar]
  24. Yosita K. Wanna C. Kesara N-B. Herbal medicine for psoriasis and their molecular targets: A systematic review. Afr. J. Pharm. Pharmacol. 2022 16 3 27 52 10.5897/AJPP2022.5292
    [Google Scholar]
  25. Soltani A. Dictionary of Medicinal Plants. Tehran Arjmand Press 2004
    [Google Scholar]
  26. Ghahraman A. Matching the Old Medicinal Plant Names with Scientific Terminology. Tehran Tehran University Press 2004
    [Google Scholar]
  27. Khare C.P. Indian Medicinal Plants. New York Springe 2007 10.1007/978‑0‑387‑70638‑2
    [Google Scholar]
  28. Damevska K. Neloska L. Nikolovska S. Gocev G. Duma S. Complementary and alternative medicine use among patients with psoriasis. Dermatol. Ther. 2014 27 5 281 283 10.1111/dth.12139 24964349
    [Google Scholar]
  29. Kim J.Y. Lee W.J. Lee S.J. Kim D.W. Kim T.H. Jun J.B. An investigation on the use of complementary and alternative medicine for psoriasis. Korean J. Dermatol. 2010 48 6 494 502
    [Google Scholar]
  30. Ben-Arye E. Ziv M. Frenkel M. Lavi I. Rosenman D. Complementary medicine and psoriasis: Linking the patient’s outlook with evidence-based medicine. Dermatology 2003 207 3 302 307 10.1159/000073094 14571074
    [Google Scholar]
  31. Le Moigne M. Sommet A. Lapeyre-Mestre M. Bourrel R. Molinier L. Paul C. Montastruc J.L. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: A cohort analysis in the French insurance database. J. Eur. Acad. Dermatol. Venereol. 2014 28 9 1235 1244 10.1111/jdv.12318 24236509
    [Google Scholar]
  32. Rasanan F.M. Kenari H.M. Ghassemi M. Sabbagh A.J. Aliasl J. Ghobadi A. Non-pharmacological treatments of psoriasis in persian medicine a narrative review. J. Pharmacopuncture 2022 25 1 1 6 10.3831/KPI.2022.25.1.1 35371587
    [Google Scholar]
  33. Kim G.W. Park J.M. Chin H.W. Ko H.C. Kim M.B. Kim J.Y. Lee S.J. Kim D.W. Lee D. Kim B.S. Comparative analysis of the use of complementary and alternative medicine by Korean patients with androgenetic alopecia, atopic dermatitis and psoriasis. J. Eur. Acad. Dermatol. Venereol. 2013 27 7 827 835 10.1111/j.1468‑3083.2012.04583.x 22620682
    [Google Scholar]
  34. Gaston L. Crombez J-C. Lassonde M. Bernier-Buzzanga J. Hodgins S. Psychological stress and psoriasis: Experimental and prospective correlational studies. Acta Derm. Venereol. Suppl. (Stockh.) 1991 156 37 43 2048373
    [Google Scholar]
  35. Tausk F. Whitmore S.E. A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother. Psychosom. 1999 68 4 221 225 10.1159/000012336 10396014
    [Google Scholar]
  36. Yang Z. Zeng B. Tang X. Wang H. Wang C. Yan Z. Huang P. Pan Y. Xu B. MicroRNA-146a and miR-99a are potential biomarkers for disease activity and clinical efficacy assessment in psoriasis patients treated with traditional Chinese medicine. J. Ethnopharmacol. 2016 194 727 732 10.1016/j.jep.2016.08.028 27562321
    [Google Scholar]
  37. Song P. Lysvand H. Yuhe Y. Liu W. Iversen O.J. Expression of the psoriasis-associated antigen, Pso p27, is inhibited by Traditional Chinese Medicine. J. Ethnopharmacol. 2010 127 1 171 174 10.1016/j.jep.2009.09.030 19781613
    [Google Scholar]
  38. Shan C. Treatment of psoriasis vulgaris by oral administration of Yin Xie Ping granules--clinical report of 60 cases. J. Chin. Med. 2007 83 76 77
    [Google Scholar]
  39. Yan Y Liu W Andres P Pernin C Chantalat L Briantais P Exploratory clinical trial to evaluate the efficacy of a topical traditional Chinese herbal medicine in psoriasis vulgaris. Evid Based Complement Alternat Med. 2015 2015 719641 10.1155/2015/719641
    [Google Scholar]
  40. Zhang L. Bai Y. Song P. You L. Yang D. Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type. Chin. J. Integr. Med. 2009 15 2 141 144 10.1007/s11655‑009‑0145‑5 19407953
    [Google Scholar]
  41. Ho S.G.Y. Yeung C.K. Chan H.H.L. Methotrexate versus traditional Chinese medicine in psoriasis: A randomized, placebo-controlled trial to determine efficacy, safety and quality of life. Clin. Exp. Dermatol. 2010 35 7 717 722 10.1111/j.1365‑2230.2009.03693.x 19925489
    [Google Scholar]
  42. Michalsen A. Eddin O. Salama A. A case series of the effects of a novel composition of a traditional natural preparation for the treatment of psoriasis. J. Tradit. Complement. Med. 2016 6 4 395 398 10.1016/j.jtcme.2015.08.006 27774425
    [Google Scholar]
  43. Jeon Y.C. Treatment for an adult patient with psoriasis with traditional Korean medicine, especially Sa-Am acupuncture and herbal medicine. J. Acupunct. Meridian Stud. 2016 9 2 88 92 10.1016/j.jams.2016.01.008 27079230
    [Google Scholar]
  44. Bedi M.K. Shenefelt P.D. Herbal therapy in dermatology. Arch. Dermatol. 2002 138 2 232 242 10.1001/archderm.138.2.232 11843645
    [Google Scholar]
  45. Cavalchini A. Scoglio S. Complementary treatment of psoriasis with an AFA-phycocyanins product: A preliminary 10-cases study. International Medical Journal. Int. Med. J. 2009 16 3 221 224
    [Google Scholar]
  46. Madland T.M. Björkkjaer T. Brunborg L.A. Fröyland L. Berstad A. Brun J.G. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. J. Rheumatol. 2006 33 2 307 310 16465662
    [Google Scholar]
  47. Lin Y.K. See L.C. Huang Y.H. Chang Y.C. Tsou T.C. Lin T.Y. Lin N.L. Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: A randomized, observer-blind, vehicle-controlled trial. Phytomedicine 2014 21 7 1015 1020 10.1016/j.phymed.2014.02.013 24680615
    [Google Scholar]
  48. Lassus A. Forsström S. A double-blind study comparing oleum horwathiensis with placebo in the treatment of psoriasis. J. Int. Med. Res. 1991 19 2 137 146 10.1177/030006059101900207 1864450
    [Google Scholar]
  49. Ellis C.N. Berberian B. Sulica V.I. Alan Dodd W. Jarratt M.T. Katz H.I. Prawer S. Krueger G. Rex I.H. Jr Wolf J.E. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J. Am. Acad. Dermatol. 1993 29 3 438 442 10.1016/0190‑9622(93)70208‑B 7688774
    [Google Scholar]
  50. Syed T.A. Ahmad S.A. Holt A.H. Ahmad S.A. Ahmad S.H. Afzal M. Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo‐controlled, double‐blind study. Trop. Med. Int. Health 1996 1 4 505 509 10.1046/j.1365‑3156.1996.d01‑91.x 8765459
    [Google Scholar]
  51. Paulsen E. Korsholm L. Brandrup F. A double‐blind, placebo‐controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J. Eur. Acad. Dermatol. Venereol. 2005 19 3 326 331 10.1111/j.1468‑3083.2004.01186.x 15857459
    [Google Scholar]
  52. Pandey S. Jha A. Kaur V. Aqueous extract of neem leaves in treatment of psoriasis vulgaris. Indian J. Dermatol. Venereol. Leprol. 1994 60 2 63
    [Google Scholar]
  53. Bernstein S. Donsky H. Gulliver W. Hamilton D. Nobel S. Norman R. Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract--a double-blind, placebo-controlled study. Am. J. Ther. 2006 13 2 121 126 10.1097/00045391‑200603000‑00007 16645428
    [Google Scholar]
  54. Cui B-N Sun Y-X Liu W-L Clinical efficacy of narrow band ultraviolet bin combined with yuyin recipe in treating psoriasis vulgaris. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008 28 4 355 7
    [Google Scholar]
  55. Strong A.M.M. Hamill E. The effect of combined fish oil and evening primrose oil (Efamol Marine) on the remission phase of psoriasis: A 7-month double-blind randomized placebo-controlled trial. J. Dermatolog. Treat. 1993 4 1 33 36 10.3109/09546639309088234
    [Google Scholar]
  56. Oliwiecki S. Burton J.L. Evening primrose oil and marine oil in the treatment of psoriasis. Clin. Exp. Dermatol. 1994 19 2 127 129 10.1111/j.1365‑2230.1994.tb01139.x 8050140
    [Google Scholar]
  57. Ahmadi A. Barikbin B. Naseri M. Mohagheghi M. The effect of HESA-A on psoriasis vulgaris. J. Drugs Dermatol. 2008 7 6 559 561 18561587
    [Google Scholar]
  58. Gupta A.K. Ellis C.N. Goldfarb M.T. Hamilton T.A. Voorhees J.J. The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis. Int. J. Dermatol. 1990 29 8 591 595 10.1111/j.1365‑4362.1990.tb03477.x 2242951
    [Google Scholar]
  59. Veale D.J. Torley H.I. Richards I.M. O’Dowd A. Fttzsimons C. Belch J.J.F. Sturrock R.D. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. Rheumatology (Oxford) 1994 33 10 954 958 10.1093/rheumatology/33.10.954 7921757
    [Google Scholar]
  60. Stücker M. Memmel U. Hoffmann M. Hartung J. Altmeyer P. Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology 2001 203 2 141 147 10.1159/000051729 11586013
    [Google Scholar]
  61. Song P Yan Z Xu X Clinical observation on effect of compound E-bei ointment in treating plaque psoriasis. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007 27 4 352 4
    [Google Scholar]
  62. Perera GK Ainali C Semenova E Hundhausen C Barinaga G Kassen D Integrative biology approach identifies cytokine targeting strategies for psoriasis. Sci. Transl. Med. 2014 6 224 223ra22 10.1126/scitranslmed.3007217
    [Google Scholar]
  63. Serwin A.B. Sokolowska M. Chodynicka B. Tumour necrosis factor α (TNF‐α)‐converting enzyme (TACE) and soluble TNF‐α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Photodermatol. Photoimmunol. Photomed. 2007 23 4 130 134 10.1111/j.1600‑0781.2007.00296.x 17598866
    [Google Scholar]
  64. Altemus M. Rao B. Dhabhar F.S. Ding W. Granstein R.D. Stress-induced changes in skin barrier function in healthy women. J. Invest. Dermatol. 2001 117 2 309 317 10.1046/j.1523‑1747.2001.01373.x 11511309
    [Google Scholar]
  65. Naldi L. Parazzini F. Peli L. Chatenoud L. Cainelli T. Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br. J. Dermatol. 1996 134 1 101 106 8745893
    [Google Scholar]
  66. Dayanand N.D. Amuthan A. Ballambat S.P. Kabbekodu S.P. Devi V. Indian traditional treatments for Psoriasis: A critical appraisal of available evidence supporting efficacy. Chin. J. Integr. Med. 2023 29 1 69 73 10.1007/s11655‑022‑3519‑y 35829957
    [Google Scholar]
  67. Parker S. Zhang C.S. Yu J.J. Lu C. Zhang A.L. Xue C.C. Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: A systematic review. J. Dermatolog. Treat. 2017 28 1 21 31 10.1080/09546634.2016.1178377 27366921
    [Google Scholar]
  68. May B.H. Zhang A.L. Zhou W. Lu C. Deng S. Xue C.C.L. Oral herbal medicines for psoriasis: A review of clinical studies. Chin. J. Integr. Med. 2012 18 3 172 178 10.1007/s11655‑012‑1008‑z 22466940
    [Google Scholar]
  69. Wen Z.H. Xuan M.L. Yan Y.H. Li X.Y. Yao D.N. Li G. Guo X.F. Ou A.H. Lu C.J. Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): Study protocol for a randomized controlled trial. Trials 2014 15 1 2172 10.1186/1745‑6215‑15‑294 25052161
    [Google Scholar]
  70. Li L. Zhang H. Zhong X. Lu Y. Wei J. Li L. Chen H. Lu C. Han L. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Life Sci. 2020 243 117231 10.1016/j.lfs.2019.117231 31887296
    [Google Scholar]
  71. Yang X. Cai W. Guo C. Chen Q. Chinese medicine as supporting therapy for psoriasis: Past, present, and future. Chin. J. Integr. Med. 2023 29 3 280 288 10.1007/s11655‑022‑3683‑8 36301454
    [Google Scholar]
  72. Luo Y. Chen J. Kuai L. Zhang Y. Ding X. Luo Y. Ru Y. Xing M. Li H. Sun X. Li B. Li X. Chinese herbal medicine for psoriasis: Evidence from 11 high-quality randomized controlled trials. Front. Pharmacol. 2021 11 599433 10.3389/fphar.2020.599433 33551804
    [Google Scholar]
  73. Zhou D. Chen W. Li X. Deng B. Xu W. Qu J. Zhang G. Zhang C. Sun L. Jiang C. Xu J. Li P. Chen J. Duan Y. Yang Z. Bai Y. Liu W. Qu X. Wang P. Liu J. Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi). Eur. J. Integr. Med. 2014 6 2 135 146 10.1016/j.eujim.2014.01.010
    [Google Scholar]
  74. Rahbar M. Zarei A. Ranjbar M. Tabarrai M. Shirbeigi L. Etiology, clinical manifestation and natural treatments of psoriasis from the perspective of Persian medicine. Trad. Integrat. Med. 2023 2023 252
    [Google Scholar]
  75. Siefring ML Lu D States JC Van Hoang M Rapid onset of multiple concurrent squamous cell carcinomas associated with the use of an arsenic-containing traditional medicine for chronic plaque psoriasis. BMJ Case Rep 2018 2018 bcr2017222645
    [Google Scholar]
  76. Couderc S. Lapeyre-Mestre M. Bourrel R. Paul C. Montastruc J.L. Sommet A. Infectious risk of biological drugs vs. traditional systemic treatments in moderate‐to‐severe psoriasis: A cohort analysis in the French insurance database. Fundam. Clin. Pharmacol. 2018 32 4 436 449 10.1111/fcp.12358 29446857
    [Google Scholar]
  77. Yamanaka K. Yamamoto O. Honda T. Pathophysiology of psoriasis: A review. J. Dermatol. 2021 48 6 722 731 10.1111/1346‑8138.15913 33886133
    [Google Scholar]
  78. Niculet E. Radaschin D. Nastase F. Draganescu M. Baroiu L. Miulescu M. Arbune M. Tatu A. Influence of phytochemicals in induced psoriasis (Review). Exp. Ther. Med. 2020 20 4 3421 3424 10.3892/etm.2020.9013 32905089
    [Google Scholar]
  79. Dabholkar N. Rapalli V.K. Singhvi G. Potential herbal constituents for psoriasis treatment as protective and effective therapy. Phytother. Res. 2021 35 5 2429 2444 10.1002/ptr.6973 33277958
    [Google Scholar]
  80. Wang S. Zhu L. Xu Y. Qin Z. Xu A. Salvianolic acid B ameliorates psoriatic changes in imiquimod-induced psoriasis on BALB/c mice by inhibiting inflammatory and keratin markers via altering phosphatidylinositol-3-kinase/protein kinase B signaling pathway. Korean J. Physiol. Pharmacol. 2020 24 3 213 221 10.4196/kjpp.2020.24.3.213 32392912
    [Google Scholar]
  81. Lan X.O. Wang H.X. Qi R.Q. Xu Y.Y. Yu Y.J. Yang Y. Guo H. Gao X.H. Geng L. Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model. Mol. Med. Rep. 2020 22 3 2263 2272 10.3892/mmr.2020.11315 32705251
    [Google Scholar]
  82. Li X. Xie X. Zhang L. Meng Y. Li N. Wang M. Zhai C. Liu Z. Di T. Zhang L. Li P. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway. Life Sci. 2019 219 311 321 10.1016/j.lfs.2019.01.019 30658103
    [Google Scholar]
  83. Liu G. Wang Z. Li X. Liu R. Li B. Huang L. Chen Y. Zhang C. Zhang H. Li Y. Chen Y. Yin H. Fang W. Total glucosides of paeony (TGP) alleviates constipation and intestinal inflammation in mice induced by Sjögren’s syndrome. J. Ethnopharmacol. 2020 260 113056 10.1016/j.jep.2020.113056 32525066
    [Google Scholar]
  84. Zhu H. Wang X. Wang X. Liu B. Yuan Y. Zuo X. Curcumin attenuates inflammation and cell apoptosis through regulating NF-κB and JAK2/STAT3 signaling pathway against acute kidney injury. Cell Cycle 2020 19 15 1941 1951 10.1080/15384101.2020.1784599 32615888
    [Google Scholar]
  85. Sakthi Priyadarsini S. Vani P.B. Kumar P.R. A comparative review on conventional and traditional medicine in the treatment of Psoriasis. Res. J. Pharm. and Tech. 2020 13 11 5642 5646
    [Google Scholar]
  86. Chen Z. Ding W. Yang X. Lu T. Liu Y. Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases. J. Ethnopharmacol. 2024 318 Pt B 117059 10.1016/j.jep.2023.117059 37604329
    [Google Scholar]
  87. Cai S.Q. Tang Z.M. Xiong C. Wu F.F. Zhao J.R. Zhang Q. Wang L. Zhang X.N. Zhao X.H. The anti-inflammatory effects of apigenin and genistein on the rat intestinal epithelial (IEC-6) cells with TNF-α stimulation in response to heat treatment. Curr. Res. Food Sci. 2022 5 918 926 10.1016/j.crfs.2022.05.011 36686365
    [Google Scholar]
  88. Ahmad S. Parveen A. Parveen B. Parveen R. Challenges and guidelines for clinical trial of herbal drugs. J. Pharm. Bioallied Sci. 2015 7 4 329 333 10.4103/0975‑7406.168035 26681895
    [Google Scholar]
  89. Wang X.W. Operational guidance: Information needed to support clinical trials of herbal products. Chinese J. Clin. Pharmacol Therapeut. 2005 12 5 582
    [Google Scholar]
  90. Singh H.P. Sharma S. Chauhan S.B. Kaur I. Clinical trials of traditional herbal medicines in India: Current status and challenges. Int J Pharmacogn. 2014 1 7 415 421
    [Google Scholar]
  91. Ameh S.J. Obodozie O.O. Abubakar M.S. Garba M. Current phytotherapy–an inter-regional perspective on policy, research and development of herbal medicine. J. Med. Plants Res. 2010 4 15 1508 6
    [Google Scholar]
  92. Skalli S. Bencheikh R.S. Safety monitoring of herb-drug interactions: A component of pharmacovigilance. Drug Saf. 2012 35 10 785 791 10.1007/BF03261975 22876741
    [Google Scholar]
  93. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014 4 177 10.3389/fphar.2013.00177 24454289
    [Google Scholar]
  94. Elkhawaga O.Y. Ellety M.M. Mofty S.O. Ghanem M.S. Mohamed A.O. Review of natural compounds for potential psoriasis treatment. Inflammopharmacology 2023 31 3 1183 1198 10.1007/s10787‑023‑01178‑0 36995575
    [Google Scholar]
  95. Gaikwad R.G. Shinde A.J. Hajare A.A. Herbal treatment for management of psoriasis: An overview. Res J Pharm Technol 2022 15 3 1385 1392 10.52711/0974‑360X.2022.00231
    [Google Scholar]
  96. Bahuguna S. Joshi D. Singh B. Semwal N. A review on novel pharmaceutical approaches of herbal drugs in derma care. ADermatol & Cosmet JOJ. 2021 4 2 555631
    [Google Scholar]
  97. Jyothi S.L. Krishna K.L. Ameena Shirin V.K. Sankar R. Pramod K. Gangadharappa H.V. Drug delivery systems for the treatment of psoriasis: Current status and prospects. J. Drug Deliv. Sci. Technol. 2021 62 102364 10.1016/j.jddst.2021.102364
    [Google Scholar]
  98. Kumar A. Singh S. Kumar B. Baghel D.S. Sati B. Chandra P. An overview on Anti psoriasis phytocomponents used in novel drug delivery systems. AIP Conf. Proc. 2986, 030068 2024 2986 1 030068 10.1063/5.0192537
    [Google Scholar]
/content/journals/cddt/10.2174/0115701638327441241016014503
Loading
An Update on Clinically Evaluated Medicinal Plants for Psoriasis Management
Bentham Science Publishers ; https://doi.org/10.2174/0115701638327441241016014503
/content/journals/cddt/10.2174/0115701638327441241016014503
/content/journals/cddt/10.2174/0115701638327441241016014503
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: clinical ; anti-inflammatory ; herbal ; psoriasis ; Complementary medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test